Light Conversion Nanomaterials for Wireless Phototherapy.


Journal

Accounts of chemical research
ISSN: 1520-4898
Titre abrégé: Acc Chem Res
Pays: United States
ID NLM: 0157313

Informations de publication

Date de publication:
16 05 2023
Historique:
medline: 17 5 2023
pubmed: 11 3 2023
entrez: 10 3 2023
Statut: ppublish

Résumé

Phototherapy including optogenetics, photodynamic therapy (PDT), photothermal therapy (PTT), and photoimmunotherapy (PIT) has been proven to be effective against different diseases. However, as the name suggests, phototherapy requires light irradiation, thus its therapeutic efficiency is often restricted by limited depth of light penetration within biological tissue. This light penetration limitation is significantly adverse to PDT and optogenetics because both therapies are usually activated with UV and visible light of very poor tissue penetration efficiency. Current light delivery methods usually involve cumbersome setups and require optical fiber or catheter insertion, which not only restrict the movement of patients but also impose incompatibility issues with chronic implantation. To address the existing challenges, wireless phototherapy was developed through various approaches over recent years, which usually relies on implantable wireless electronic devices. However, the application of wireless electronic devices is limited by invasion during implantation, unwanted heat generation, and adverse immunogenicity of these devices.Over the recent years, applying light conversion nanomaterials as light transducers for wireless phototherapy has garnered much interest. Compared with implantable electronic devices and optical fiber, nanomaterials can be easily injected into the body with minimal invasiveness and can also be surface functionalized to increase their biocompatibility and cell accumulation efficiency. Commonly applied light conversion nanomaterials include upconversion nanoparticles (UCNPs), X-ray nanoscintillators, and persistent luminescence nanoparticles (PLNPs). UCNPs and X-ray nanoscintillators can respectively convert near-infrared (NIR) light and X-ray, which have good tissue penetration efficiency, to UV or visible light, which is suitable for activating phototherapy. PLNPs can be excited by external light such as X-rays and NIR light and retain long afterglow luminescence after the removal of the excitation light source. As a result, applying PLNPs in phototherapy can potentially reduce irradiation time from external light sources, thus minimizing tissue photodamage. This Account aims to briefly discuss (i) the mechanisms of different phototherapies, (ii) the development and mechanisms of light conversion nanomaterials, (iii) the application of light conversion nanomaterials in wireless phototherapy, highlighting how they relieve current challenges in phototherapy, and (iv) perspectives for future development of light conversion nanomaterials for wireless phototherapy.

Identifiants

pubmed: 36897248
doi: 10.1021/acs.accounts.2c00699
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1143-1155

Auteurs

Bowen Sun (B)

Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore 117583, Singapore.

Jia Yee Teo (JY)

Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore 117583, Singapore.

Jiaxi Wu (J)

NUS Graduate School, Integrative Sciences and Engineering Programme (ISEP), National University of Singapore, Singapore 119077, Singapore.

Yong Zhang (Y)

Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore 117583, Singapore.
NUS Graduate School, Integrative Sciences and Engineering Programme (ISEP), National University of Singapore, Singapore 119077, Singapore.
NUS Suzhou Research Institute, Suzhou, Jiangsu 215000, P. R. China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH